MA
IMDZ

MUFG Americas’s Immune Design Corp. IMDZ Stock Holding History

MUFG Americas’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-271
Closed -$3K – 1221
2017
Q3 		$3K Hold
271
– – ﹤0.01% 1029
2017
Q2 		$3K Buy
+271
New +$1.9K ﹤0.01% 1034
2015
Q4 		– Sell
-141
Closed -$2K – 1323
2015
Q3 		$2K Hold
141
– – ﹤0.01% 1137
2015
Q2 		$3K Buy
+141
New +$3.33K ﹤0.01% 1069

Other funds holding IMDZ

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MUFG Americas's IMDZ Position: Q4 2017 in Review

MUFG Americas sold out of Immune Design Corp. (IMDZ) in Q4 2017, closing a stake of 271 shares — an estimated $3K sold.

MUFG Americas first reported a position in IMDZ in Q2 2015 and held it in 4 quarters. The position peaked at $3K in Q3 2017. 76 funds tracked by Wall St. Rank hold IMDZ as of Q4 2017.

  • MUFG Americas reported no remaining Immune Design Corp. position as of Q4 2017 after selling out during the quarter.
  • MUFG Americas sold 271 Immune Design Corp. shares in Q4 2017, an estimated $3K.
  • MUFG Americas first reported a position in Immune Design Corp. in Q2 2015 and held it in 4 quarters.
  • MUFG Americas's Immune Design Corp. position peaked at $3K in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2017.

Based on MUFG Americas's 13F filing for Q4 2017, filed 8 Feb 2018.